Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop Wednesday. That's left many patients wondering what to do next.
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
Ex-employees of a startup bankrolled by Bill Gates' investment firm, sued the company, accusing it of exposing them to toxic ...
6d
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
The container ship which collided with an oil tanker in the North Sea was 'carrying a toxic compound' that 'can be lethal', ...
Eli Lilly in a statement said the decision “marks the end of the road for mass compounding of risky, unapproved knockoffs ...
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...
Eli Lilly in a statement said the decision “marks the end of the road for mass compounding of risky, unapproved knockoffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback